Trial Profile
Long Term Safety Trial Comparing Intensive Treatment of Pulmonary Inhaled Human Insulin [insulin] With s.c. [subcutaneous] Insulin Aspart, Both in Combination With NPH [insulin suspension isophane], in Subjects With Type 1 Diabetes Mellitus
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Mar 2017
Price :
$35
*
At a glance
- Drugs Insulin (Primary) ; Insulin aspart
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions
- Sponsors Novo Nordisk
- 09 Oct 2009 Actual end date (Dec 2004) added as reported by ClinicalTrials.gov.
- 22 Aug 2008 New trial record.